Sodium-Glucose Transporter Inhibitors and Diabetic Nephropathy in Humans and Animal Model

Autor:	Dahan Inbal, Evgeny Farber, Nakhoul Farid, Nakhoul Nakhoul, Nakhoul Rola, Hanut Anam, Koch Elias
Rok vydání:	2018
Předmět:	business.industry Insulin medicine.medical_treatment Glucose transporter Diuresis Pharmacology medicine.disease End stage renal disease Metformin Diabetic nephropathy Diabetes mellitus medicine Albuminuria medicine.symptom business medicine.drug
Zdroj:	Journal of Clinical & Experimental Nephrology.
ISSN:	2472-5056
DOI:	10.21767/2472-5056.100061
Popis:	Diabetic nephropathy as the leading cause for end stage renal disease and replacement therapy is increasing every year. Treatment of T2DM with the present oral blood glucose lowering drugs and insulin is challenging, with an enormous number of patients are able to achieve the target glycaemic control (HbA1C
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2f03c77bb4bd4f5db72d3f07fc4dedf6 https://doi.org/10.21767/2472-5056.100061 Zobrazit plný text záznamu